Dr. Susana Cantero Peral is an Associate Consultant in the Division of General Internal Medicine at Mayo Clinic, Rochester, MN. She earned her medical degree from the University of Valencia, Spain. She did her residency in Hematology and Hemotherapy, followed by a fellowship in bone marrow transplantation at the University Hospital La Fe in Valencia, Spain. As part of her training in cord blood transplantation Dr. Cantero Peral joined the Division of Hematology, Oncology and Transplantation and the Blood and Marrow Transplant Program of the University of Minnesota as a visiting scientist for 6 months. Then, she moved to the National Cord Blood Program at New York Blood Center, NY, where she spent one year as a postdoctoral fellow and 3 years as a Research scientist under Dr. Rubinstein direction. She joined the Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome at Mayo Clinic in 2011.
Dr. Cantero Peral’s research work is focused on umbilical cord blood as a source of stem cells in cardiac regeneration. Susana is the principal investigator of the umbilical cord blood collection study from HLHS patients. The cord blood collected is used in the first clinical trial in US where stem cells are injected into the heart of infants with HLHS. Her goal is to help understand the features and potency of umbilical cord blood stem cells in the cardiac regeneration field and develop novel cell-based therapies for congenital heart disease applications, such as HLHS.
There are two parts to the World Advanced Therapies & Regenerative Medicine Congress: a conference and an exhibition featuring solutions for pharma and biotech.
There is a registration fee to attend the conferences. To visit the exhibition is free.